Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes
1 other identifier
observational
133
1 country
1
Brief Summary
The specific aims of the study include:
- 1.Profile the demographic, health-related, psychosocial and behavioral characteristics of adults with MEN1 or MEN2.
- 2.Evaluate MEN-specific distress as well as adherence to surveillance regimens among adults with MEN1 or MEN2, and identify associated with those outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 12, 2007
CompletedFirst Posted
Study publicly available on registry
July 16, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 22, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 22, 2020
CompletedNovember 18, 2020
November 1, 2020
13.4 years
July 12, 2007
November 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Profile the demographic, health-related, psychosocial and behavioral characteristics of adults with MEN1 or MEN2.
3 Years
Study Arms (1)
Multiple Endocrine Neoplasia (MEN)
Patients with multiple endocrine neoplasia (MEN).
Interventions
Mailed packets including cover letter describing purpose of study, study questionnaire, and return envelope.
Eligibility Criteria
Patients with a diagnosis of MEN1 or MEN2.
You may qualify if:
- Adults age 18 years or older, with a clinical or genetic diagnosis of MEN1 or MEN2
- Spouse, Significant Other, or Family Member who is at least 18 years of age and who is related to an individual who is a patient at MDACC and who has been diagnosed with MEN1.
- Ability to read and write English
You may not qualify if:
- \) Inability to be contacted via mail (i.e., no contact information on record, incorrect address)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Peterson, PhD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2007
First Posted
July 16, 2007
Study Start
May 1, 2007
Primary Completion
September 22, 2020
Study Completion
September 22, 2020
Last Updated
November 18, 2020
Record last verified: 2020-11